Firstly, we confirmed the inhibitory effect of ML-792 on CRC cells, and found that 0.1 μM ML-792 began to inhibit the conjunction of SUMO1 and SUMO2/3 on substrates (Figure 4A). Here, SUMO1 is linked to colorectal carcinoma.